A single-center retrospective study analysing Heplisav-B Seroprotection in People with HIV in a real-world setting
Latest Information Update: 23 Nov 2020
At a glance
- Drugs Adjuvanted Hepatitis-B vaccine (Recombinant)-Dynavax (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 23 Nov 2020 New trial record
- 09 Nov 2020 Primary endpoint has been met. (seroprotection rates (SPR))
- 09 Nov 2020 Results published in the JAIDS